Sarsasapogenin(ZMS)

Short Description:


  • FOB Price: US 5 - 2000 / KG
  • Min.Order Quantity: 1 KG
  • Supply Ability: 10000 KG/per Month
  • Port: Shanghai /Beijing
  • Payment Terms: L/C,D/A,D/P,T/T,O/A
  • Shipping Terms: By sea/By Air/By Courier
  • E-mail:: info@trbextract.com
  • Product Detail

    Product Tags

    Sarsasapogenin 98% (by HPLC) – High-Purity Natural Steroid for Research & Development

    CAS No.: 126-19-2 | Molecular Formula: C27H44O3 | Molecular Weight: 416.64

    Product Overview

    Sarsasapogenin (Parigenin) is a bioactive steroidal sapogenin isolated from Anemarrhena asphodeloides Bunge, a traditional Chinese medicinal herb. With a purity of ≥98% verified by HPLC (High-Performance Liquid Chromatography), this compound is supplied as a white to beige crystalline powder, available in flexible pack sizes (0.5g, 1g, 2.5g, 5g) to meet diverse research needs. Storage conditions: +2°C to +8°C to ensure long-term stability .

    Key Specifications

    Parameter Details
    Purity ≥98% (HPLC) 
    Appearance White to beige powder
    Solubility Soluble in ethanol (5 mg/mL), insoluble in DMSO/water 
    CAS Number 126-19-2
    Molecular Formula C27H44O3
    Storage +2°C to +8°C, protected from light

    Pharmacological Effects & Therapeutic Potential

    1. Anti-Inflammatory & Immunomodulatory Activity

    Sarsasapogenin potently inhibits NF-κB and MAPK signaling pathways, suppressing pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) in LPS-stimulated macrophages . It demonstrates efficacy in colitis models by reducing neutrophil infiltration and enhancing anti-inflammatory IL-10 levels, suggesting applications in inflammatory bowel disease (IBD) therapy .

    2. Anticancer & Pro-Apoptotic Effects

    • Colorectal Cancer: Dose-dependently inhibits HT-29 cell proliferation via downregulation of KRAS and EGFR expression, inducing caspase-dependent mitochondrial apoptosis .
    • Hepatocellular Carcinoma: Triggers apoptosis in HepG2 cells by activating ER stress pathways and the unfolded protein response (UPR) .
    • Synergistic Potential: Enhances chemotherapeutic sensitivity through NF-κB pathway modulation .

    3. Neuroprotection & Cognitive Enhancement

    • Alzheimer’s Disease: Reduces Aβ plaque formation and tau hyperphosphorylation via PPARγ antagonism, improving learning/memory in rodent models .
    • Depression: Restores cholinergic function by upregulating α4/α7-nAChRs in the hippocampus and cortex, reversing depression-like behaviors in olfactory bulbectomized rats .

    4. Anti-Osteoporotic Action

    Suppresses RANKL-induced osteoclastogenesis by blocking NFATc1 transcription, preventing bone resorption in murine models. This positions it as a candidate for osteoporosis and rheumatoid arthritis treatment .

    5. Antidiabetic & Metabolic Benefits

    Emerging studies indicate sarsasapogenin improves insulin sensitivity and reduces hyperglycemia in diabetic models, potentially via PPARγ-mediated pathways .

    Applications in Research & Industry

    1. Pharmaceutical Development: Core scaffold for synthesizing derivatives with enhanced bioactivity (e.g., Timosaponin A1) .
    2. Nutraceuticals: Neuroprotective and anti-aging formulations targeting cognitive decline.
    3. Cosmeceuticals: Anti-inflammatory and antioxidant properties for skincare products.
    4. Veterinary Medicine: Potential use in bone health and metabolic disorder management.

    Quality Assurance & Compliance

    • Certification: Batch-specific HPLC chromatograms and MS data provided (Example: Sigma-Aldrich Lot S8534) .
    • Safety: Acute toxicity studies show low adverse effects in rodents (LD50 >2g/kg), though chronic toxicity data remain limited .
    • Regulatory: Compliant with USP/EP standards for biochemical reagents.

    Keywords

    • High-purity sarsasapogenin HPLC 98%
    • Natural steroid sapogenin for inflammation
    • Sarsasapogenin anticancer mechanism
    • Neuroprotective agent CAS 126-19-2
    • Osteoporosis treatment NFATc1 inhibitor

    Frequently Asked Questions (FAQs)

    Q: Is sarsasapogenin safe for human trials?
    A: Current data support preclinical safety, but clinical studies are ongoing to validate efficacy and dosage .

    Q: Can it be used in combination therapies?
    A: Yes, synergistic effects with chemotherapeutics (e.g., 5-FU) and anti-inflammatory drugs are under investigation .

    Ordering Information

    Contact us for bulk pricing and custom synthesis. Global shipping available with cold-chain logistics for temperature-sensitive batches.

     


  • Previous:
  • Next: